Items where authors include "Chalmers, A.J."

Article

Rominiyi, O. orcid.org/0000-0002-9724-0224, McGarrity-Cottrell, C., Myers, K.N. orcid.org/0000-0002-1951-4744 et al. (16 more authors) (2024) Ex-vivo models of post-surgical residual disease in human glioblastoma [version 1; peer review: awaiting peer review]. F1000Research, 13. 1316. ISSN 2046-1402

Derby, S., Dutton, L., Strathdee, K.E. et al. (27 more authors) (2024) Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalisation via macropinocytosis. Neuro-Oncology, 26 (4). pp. 625-639. ISSN 1522-8517

Walker, K. orcid.org/0000-0001-6922-9100, Hinsley, S., Phillip, R. orcid.org/0000-0002-9604-9276 et al. (6 more authors) (2022) Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE. JCO Precision Oncology, 6 (6). e2200133. ISSN 2473-4284

Proceedings Paper

Greystoke, A., Oughton, J.B., Brown, S.R. et al. (16 more authors) (2024) Olaparib, AZD1390, ceralasertib, saruparib and consolidation durvalumab (CONCORDE) phase Ib platform study of novel DNA damage response inhibitor (DDRi) agents in combination with radiotherapy in non-small cell lung cancer (NSCLC). In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. ASCO Publications .

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier BV , S296-S297.

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier , S296-S297.